Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Freemen Nutra Group and RAWGA Inc. Launch Hibiscus Peptide Ingredient for Skin Health - Nutraceuticals World

What are you searching for?

Sign in
Products & Ingredients

Freemen Nutra Group and RAWGA Inc. Launch Hibiscus Peptide Ingredient for Skin Health

A 12-week study found that the plant-based collagen alternative supported skin hydration, firmness, and appearance.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Photo: thayra83 | Adobe Stock

Freemen Nutra and Rawga, Inc. have partnered to launch VC-H1, a plant-based bioactive peptide, in the North American Market.

The ingredient is sourced from organically-grown hibiscus, and is comprised of bioactive peptides from a collagen-like protein, along with hibiscus polyphenols. VC-H1 has been shown to support collagen production in the skin, with additional skin health benefits, and is positioned as an alternative to animal-based collagen peptides.

“We are excited to be working with Freemen Nutra to bring VC-H1 to the U.S. and Canada,” said Raw Kim, founder and CEO of Rawga, Inc. “This partnership marks a significant milestone in our quest to create more healthy, safe, and sustainable food systems.”

“We see this as a tremendous opportunity to bring our customers, especially those with a focus on sustainability, a research-backed ingredient in a high demand category,” said Hanks Li, president of Freemen Nutra. “VC-H1 is not only an innovative option within the collagen market, but with a 1.5-gram dose, many if not most of our customers will also see a cost savings. That is truly a rare opportunity.”

A randomized, double-blind, placebo-controlled clinical trial published in the International Journal of Molecular Sciences found that, compared to a placebo, VC-H1 significantly improved skin hydration; bounce and firmness; measures of skin health at the surface; and beneficial changes in age-related measures.

“The key to the efficacy of VC-H1, and any collagen really, are the short two-to-four amino acid length peptides that stimulate collagen production in the body,” said Eric Withee, director of innovation at Freemen Nutra. “VC-H1 has a very low molecular weight, meaning it is made almost entirely of these collagen-boosting peptides.”

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics